47 related articles for article (PubMed ID: 34207401)
1. Immune profiling of dedifferentiated liposarcoma and identification of novel antigens for targeted immunotherapy.
Jirovec A; Flaman A; Godbout E; Serrano D; Werier J; Purgina B; Diallo JS
Sci Rep; 2024 May; 14(1):11254. PubMed ID: 38755218
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive serum and tissue microRNA profiling in dedifferentiated liposarcoma.
Kohama I; Asano N; Matsuzaki J; Yamamoto Y; Yamamoto T; Takahashi RU; Kobayashi E; Takizawa S; Sakamoto H; Kato K; Fujimoto H; Chikuda H; Kawai A; Ochiya T
Oncol Lett; 2021 Aug; 22(2):623. PubMed ID: 34285721
[TBL] [Abstract][Full Text] [Related]
3. Genetic, Epigenetic and Transcriptome Alterations in Liposarcoma for Target Therapy Selection.
Lesovaya EA; Fetisov TI; Bokhyan BY; Maksimova VP; Kulikov EP; Belitsky GA; Kirsanov KI; Yakubovskaya MG
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254762
[TBL] [Abstract][Full Text] [Related]
4. Clinical and molecular approaches to well differentiated and dedifferentiated liposarcoma.
Crago AM; Singer S
Curr Opin Oncol; 2011 Jul; 23(4):373-8. PubMed ID: 21552124
[TBL] [Abstract][Full Text] [Related]
5. [Retroperitoneal dedifferentiated liposarcoma (DDLS) with hyperglycemic activity: case report and literature review].
Parmeggiani D; Avenia N; De Falco M; Bilancio G; Ruggero R; Docimo G; Gubitosi A; Fiore A; Atelli P; Misso C; Mordente S; Parmeggiani U
Minerva Chir; 2010 Aug; 65(4):479-84. PubMed ID: 20802435
[TBL] [Abstract][Full Text] [Related]
6. Gene Expression Changes Associated with Dedifferentiation in Liposarcoma Predict Overall Survival.
Shannon NB; Tan QX; Tan JW; Hendrikson J; Ng WH; Ng G; Liu Y; Tan GHC; Wong JSM; Soo KC; Teo MCC; Chia CS; Ong CJ
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34207401
[TBL] [Abstract][Full Text] [Related]
7. Retroperitoneal liposarcomas: follow-up analysis of dedifferentiation after clinicopathologic reexamination of 86 liposarcomas and malignant fibrous histiocytomas.
Fabre-Guillevin E; Coindre JM; Somerhausen Nde S; Bonichon F; Stoeckle E; Bui NB
Cancer; 2006 Jun; 106(12):2725-33. PubMed ID: 16688768
[TBL] [Abstract][Full Text] [Related]
8. Copy number losses define subgroups of dedifferentiated liposarcoma with poor prognosis and genomic instability.
Crago AM; Socci ND; DeCarolis P; O'Connor R; Taylor BS; Qin LX; Antonescu CR; Singer S
Clin Cancer Res; 2012 Mar; 18(5):1334-40. PubMed ID: 22241790
[TBL] [Abstract][Full Text] [Related]
9. Clinical features of multiply recurrent retroperitoneal liposarcoma: A single-center experience.
Masaki N; Onozawa M; Inoue T; Kurobe M; Kawai K; Miyazaki J
Asian J Surg; 2021 Jan; 44(1):380-385. PubMed ID: 33191070
[TBL] [Abstract][Full Text] [Related]
10. Amplification of FRS2 in atypical lipomatous tumour/well-differentiated liposarcoma and de-differentiated liposarcoma: a clinicopathological and genetic study of 146 cases.
Jing W; Lan T; Chen H; Zhang Z; Chen M; Peng R; He X; Zhang H
Histopathology; 2018 Jun; 72(7):1145-1155. PubMed ID: 29368794
[TBL] [Abstract][Full Text] [Related]
11. Immunoreactivity of p53, mdm2, and p21WAF1 in dedifferentiated liposarcoma: special emphasis on the distinct immunophenotype of the well-differentiated component.
Adachi T; Oda Y; Sakamoto A; Saito T; Tamiya S; Masuda K; Tsuneyoshi M
Int J Surg Pathol; 2001 Apr; 9(2):99-109. PubMed ID: 11484509
[TBL] [Abstract][Full Text] [Related]
12. Soft-tissue sarcoma in adults: An update on the current state of histiotype-specific management in an era of personalized medicine.
Gamboa AC; Gronchi A; Cardona K
CA Cancer J Clin; 2020 May; 70(3):200-229. PubMed ID: 32275330
[TBL] [Abstract][Full Text] [Related]
13. Applicability of the Sarculator and MSKCC nomograms to retroperitoneal sarcoma prognostication in an Asian tertiary center.
Wong RX; Koh YS; Ong F; Farid M; Tay TKY; Teo M
Asian J Surg; 2020 Nov; 43(11):1078-1085. PubMed ID: 31941593
[TBL] [Abstract][Full Text] [Related]
14. Novel nomograms individually predict the survival of patients with soft tissue sarcomas after surgery.
Zhang SL; Wang ZM; Wang WR; Wang X; Zhou YH
Cancer Manag Res; 2019; 11():3215-3225. PubMed ID: 31114361
[No Abstract] [Full Text] [Related]
15. Well-differentiated liposarcoma and dedifferentiated liposarcoma: An updated review.
Thway K
Semin Diagn Pathol; 2019 Mar; 36(2):112-121. PubMed ID: 30852045
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
